Shah M, Mamtani R, Marmarelis ME, Hennessy S, et al. Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression >/=50% or >/=90. Clin Lung Cancer 2023 Mar 1:S1525-7304(23)00038.
PMID: 36935244